PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaCommercial · Coverage · Medical Policy · Orthopedics, ENT (Ear, Nose & Throat), Dentistry +2 moreMedium impact

Bone and Tendon Graft Substitutes and Adjuncts (CPB 0411, reviewed 2026-08-18)

Effective date
Not stated in the notice
Identified
Oct 1, 2026

Summary

Aetna considers INFUSE Bone Graft (bone morphogenetic protein-2) medically necessary for lumbar spinal fusion in skeletally mature persons who meet CPB 0743 criteria, when implanted by an ALIF or lateral (OLIF, DLIF, XLIF or LLIF) approach or with 1 or 2 level TLIF procedures, and for acute open tibial shaft fractures stabilized with intramedullary nail fixation when applied within 14 days after the initial fracture. Cadaveric allograft and demineralized bone matrix are medically necessary for spinal fusions and for filling osteochondral defects, and PMMA or calcium sulfate antibiotic beads are medically necessary with intravenous antibiotics for chronic osteomyelitis. Aetna considers INFUSE for ankle and cervical fusions, platelet-rich plasma, and mesenchymal stem cell therapy for orthopedic applications experimental, investigational or unproven.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01Billing team: bill INFUSE Bone Graft as covered only for lumbar spinal fusion that meets CPB 0743 criteria and is implanted by an ALIF or lateral approach or with 1 or 2 level TLIF procedures, or for an acute open tibial shaft fracture treated within 14 days after the initial fracture.
02Do not bill INFUSE for ankle fusion, cervical fusion, 3 or more level TLIF, or posterior or postero-lateral lumbar fusion, which the policy treats as experimental, investigational or unproven.
03Bill PMMA or calcium sulfate antibiotic beads only when they are used with intravenous antibiotics for chronic osteomyelitis, and bill bone marrow injections only for unicameral or simple bone cysts.

Codes mentioned

2093020931C1762C9359C93621198111982119832070020701207024670724341M96.0Z98.1C1602S9055P9020

Original notice

Bone and Tendon Graft Substitutes and Adjuncts (CPB 0411, reviewed 2026-08-18)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account